Skip to main content
Caplight Logo









R3 Bio

R3 Bio

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.r3-bio.com/

Company Overview

R3 Bio is a biotechnology company that develops stem-cell-based in vitro research platforms designed to create human-relevant biological models for preclinical testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

in vitro modelsnew approach methodologiesNAMscellular reprogramminganimal-free testingpreclinical drug discoverystem-cell researchcontract research organizationCROtoxicology testingorgan-on-a-chipbiological modelingdrug safety testingcomputational biologyalternative testing methods

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

R3 Bio Comparables

Compare R3 Bio with similar companies based on industry and business-model similarity.

R3 Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Axol Bioscience
85%
pixlbio
84%
Qureator
84%

R3 Bio Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

R3 Bio Investors

Notable investors and investment history

R3 Bio investors
InvestorRounds
Immortal DragonsSeed

R3 Bio Filings

Explore SEC and related filing metadata, where available.

R3 Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about R3 Bio's valuation, stock price, and market status.

Is R3 Bio a public or private company?

R3 Bio is a private company.

What is the current stock price of R3 Bio?

R3 Bio is a private company with no public stock price. Caplight tracks R3 Bio's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is R3 Bio worth (valuation)?

Valuation information for R3 Bio is not publicly available.

Can I buy R3 Bio stock?

R3 Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was R3 Bio's last funding round?

Funding round information for R3 Bio is not publicly available.

Who are the main investors in R3 Bio?

Key investors in R3 Bio include Immortal Dragons.

Will R3 Bio IPO soon?

No public IPO plans have been announced for R3 Bio.

How can I track R3 Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor R3 Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Year Founded2025
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?